Commercial Services · Miscellaneous Commercial Services · NSE: SYNGENE · data 2026-10-09

Syngene International Ltd.

Health check: Weak (1.8/10 on quality, valuation vs sector, growth and momentum).

Open full analysis — chart, results, balance sheet, red flags →

Key figures

Price

₹347.4

Market cap

₹13,955 cr

P/E

63.3

P/B

2.9

ROE

6.6%

ROCE

9.9%

Debt / equity

0.09

Dividend yield

0.36%

1-year return

-44.9%

52-week high

₹678.95

52-week low

₹344.45

Operating margin

12.6%

Growth

Revenue (last 12 months)	₹3,600 cr
Net profit (last 12 months)	₹221 cr
Sales growth, 3 years (yearly)	5.5%
Profit growth, 3 years (yearly)	-12.0%

Similar companies

eClerx Services Limited (ECLERX) · Choice International Limited (CHOICEIN) · Central Mine Planning & Design Institute Limited (CMPDI) · Concord Biotech Ltd. (CONCORDBIO) · International Gemological Institute Ltd (IGIL)

The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.

Open SYNGENE in NSE Scanner →